InVivo (NVIV) President, CEO and CFO Frank Reynolds Resigns; Michael J. Astrue In As Interim CEO and Sean Moran in As Acting CFO
Following our coverage of InVivo (NVIV) delaying the listing of its publicly traded stock in
Recent challenges to biotechnology companies have been in the form of corporate governance issues, especially those undergoing rapid growth. Two companies in particular, InVivo (NVIV) and Amarantus Bioscience (AMBS) both stand out for their recent, respective corporate governance
One of the major obstacles of growth for Internet based Crowdfunding platforms in the U.S. has been the reaction of regulatory authorities.
However, two “no-action letters”, dated March 26, 2013, were sent by the SEC to online equity-based crowdfunding portals Funder